BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25855980)

  • 1. The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth.
    Ohashi M; Holthaus AM; Calderwood MA; Lai CY; Krastins B; Sarracino D; Johannsen E
    PLoS Pathog; 2015 Apr; 11(4):e1004822. PubMed ID: 25855980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
    Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
    J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
    Bazot Q; Paschos K; Allday MJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core binding factor (CBF) is required for Epstein-Barr virus EBNA3 proteins to regulate target gene expression.
    Paschos K; Bazot Q; Ho G; Parker GA; Lees J; Barton G; Allday MJ
    Nucleic Acids Res; 2017 Mar; 45(5):2368-2383. PubMed ID: 27903901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.
    Skalska L; White RE; Franz M; Ruhmann M; Allday MJ
    PLoS Pathog; 2010 Jun; 6(6):e1000951. PubMed ID: 20548956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression.
    Maruo S; Zhao B; Johannsen E; Kieff E; Zou J; Takada K
    Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1919-24. PubMed ID: 21245331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
    Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.
    Skalska L; White RE; Parker GA; Turro E; Sinclair AJ; Paschos K; Allday MJ
    PLoS Pathog; 2013 Feb; 9(2):e1003187. PubMed ID: 23436997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency.
    Styles CT; Bazot Q; Parker GA; White RE; Paschos K; Allday MJ
    PLoS Biol; 2017 Aug; 15(8):e2001992. PubMed ID: 28771465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A.
    Jiang S; Willox B; Zhou H; Holthaus AM; Wang A; Shi TT; Maruo S; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):421-6. PubMed ID: 24344258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.
    White RE; Groves IJ; Turro E; Yee J; Kremmer E; Allday MJ
    PLoS One; 2010 Nov; 5(11):e13979. PubMed ID: 21085583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.
    Maruo S; Wu Y; Ishikawa S; Kanda T; Iwakiri D; Takada K
    Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19500-5. PubMed ID: 17159137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa).
    Robertson ES; Lin J; Kieff E
    J Virol; 1996 May; 70(5):3068-74. PubMed ID: 8627785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr Virus Nuclear Antigen 3C Inhibits Expression of
    Gillman ACT; Parker G; Allday MJ; Bazot Q
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57KIP2.
    Bazot Q; Paschos K; Skalska L; Kalchschmidt JS; Parker GA; Allday MJ
    PLoS Pathog; 2015 Jul; 11(7):e1005031. PubMed ID: 26153983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth.
    Calderwood MA; Lee S; Holthaus AM; Blacklow SC; Kieff E; Johannsen E
    Virology; 2011 May; 414(1):19-25. PubMed ID: 21440926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV in B Cells.
    Allday MJ; Bazot Q; White RE
    Curr Top Microbiol Immunol; 2015; 391():61-117. PubMed ID: 26428372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells.
    Knight JS; Sharma N; Kalman DE; Robertson ES
    J Virol; 2004 Dec; 78(23):12857-67. PubMed ID: 15542638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth.
    Maruo S; Johannsen E; Illanes D; Cooper A; Kieff E
    J Virol; 2003 Oct; 77(19):10437-47. PubMed ID: 12970429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus nuclear antigen 3C (EBNA3C) interacts with the metabolism sensing C-terminal binding protein (CtBP) repressor to upregulate host genes.
    Ohashi M; Hayes M; McChesney K; Johannsen E
    PLoS Pathog; 2021 Mar; 17(3):e1009419. PubMed ID: 33720992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.